424.50
-20.50
(-4.61%)
At close: April 16 at 4:59:44 PM GMT+2
Breakdown
TTM
12/31/2024
12/31/2023
12/31/2022
12/31/2021
Operating Cash Flow
-930,816
-930,816
-425,668
-942,311
-1,211,971
Investing Cash Flow
-7,332,915
-7,332,915
-1,094,033
281,259
-18,121
Financing Cash Flow
8,288,491
8,288,491
907,014
587,500
1,332,751
End Cash Position
480,303
480,303
449,311
1,069,234
1,129,103
Capital Expenditure
-13,148
-13,148
-23,749
-11,710
-22,133
Issuance of Capital Stock
8,523,479
8,523,479
1,563,950
1,084,661
775,045
Issuance of Debt
369,867
369,867
--
--
647,906
Repayment of Debt
--
--
-525,764
-436,088
--
Repurchase of Capital Stock
-351,834
-351,834
-41,600
--
-28,590
Free Cash Flow
-943,964
-943,964
-449,417
-954,021
-1,234,104
12/31/2021 - 11/23/2010
Upgrade to begin using 40 years of financial statements and get so much more.
Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.
UpgradeRelated Tickers
GUBRA.CO Gubra A/S
356.00
-4.30%
BAVA.CO Bavarian Nordic A/S
151.65
+0.43%
GMAB.CO Genmab A/S
1,291.50
-0.12%
ALK-B.CO ALK-Abelló A/S
148.60
+1.36%
GMAB Genmab A/S
20.04
+2.51%
FLUO.ST FluoGuide A/S
38.00
-2.56%
ASND Ascendis Pharma A/S
165.05
+4.36%
BVNRY Bavarian Nordic A/S
7.58
+0.13%
SANION.ST Saniona AB (publ)
6.40
+4.07%
AVXL Anavex Life Sciences Corp.
8.95
+1.24%